BTN2A1 and breast carcinoma: In breast cancer, low expressions of BTN1A1, BTN2A1, BTN2A2, BTN2A3, BTN3A1, BTN3A2, BTN3A3, BTNL2, BTNL3, and BTNL9 were significantly correlated with worse OS (Figure 5C).